Search results
Results from the WOW.Com Content Network
Glucuronolactone is an ingredient used in some energy drinks [2] Although levels of glucuronolactone in energy drinks can far exceed those found in the rest of the diet. . Research into Glucuronolactone is too limited to assert claims about its safety [8] The European Food Safety Authority (EFSA) has concluded that it is unlikely that glucurono-γ-lactone would have any interaction with ...
However, drinking high-calorie energy drinks may cause weight gain if the extra calories from the drink exceed daily needs. Celsius energy drinks also contain chromium, a popular weight loss ...
Milk-alkali syndrome is an illness that is characterized by hypercalcaemia, kidney damage, and metabolic alkalosis. [17] This syndrome was discovered in the early 1900s when people began experiencing adverse effects from Bertrand Sippy's gastric ulcer treatment consisting of milk and alkali.
“Just as much as the GLP-1s are a diabetes drug and a weight loss medicine, they are brain drugs, too,” says Rekha Kumar, MD, an endocrinologist at New York-Presbyterian and Weill Cornell ...
"Remember, fat slows gastric emptying – it’s why you feel full when you eat a fatty meal." When taking GLP-1 medications, gastric emptying is already slowed, Osborn noted, which means too much ...
Serotonin is a neurotransmitter involved in multiple complex biological processes including aggression, pain, sleep, appetite, anxiety, depression, migraine, and vomiting. [10] In humans the effects of excess serotonin were first noted in 1960 in patients receiving an MAOI and tryptophan. [54] The syndrome is caused by increased serotonin in ...
Drinking sugary soda regularly may increase the risk of cancer, as obesity is a known risk factor for various types of cancer. Additionally, the caramel coloring used in some sodas contains a ...
These side effects are noted in less than 2% of patients. They require immediate termination of treatment. Clinical improvement and normalization of X-ray findings are normally seen soon after cabergoline withdrawal. It appears that the dose typically used for treatment of hyperprolactinemia is too low to cause this type of side effects.